Management and Executive

Engineering and Development

Chief Financial Officer

Senior Vice President, Head of Research

Kyverna Therapeutics Highlights Potential of KYV-101 in Rheumatoid Arthritis with Phase 1 Data from Investigator-Initiated Trial Presented at ACR Convergence 2025

Kyverna Therapeutics to Host Conference Call on Interim Phase 2 Data from KYSA-6 Study of KYV-101 in Generalized Myasthenia Gravis

KYVERNA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation Into Kyverna Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Kyverna Therapeutics announces updated data from Phase 1 IITs of KYV-101

Sr. Medical Director, Clinical Development

Kyverna Therapeutics is seeking a highly motivated Medical Director with experience in clinical development to join their team developing novel and innovative engineered T cell-based therapies for autoimmune diseases. The ideal candidate will serve as the medical lead for CAR T-cell therapy clinical trials and support the transition of preclinical projects to clinical development.

VP of Human Resources

Sr. Director, Talent Acquisition

Sign up with Google

Sign in with Google